Source : WAM
Saeed bin Mubarak Al Hajeri, Minister of State and Chairman of the Board of Directors of the Emirates Drug Establishment, affirmed that the UAE’s pharmaceutical sector continues to operate with a high degree of stability and preparedness. He highlighted that the country’s strategic stockpile of medicines and medical supplies remains secure and sufficient to meet the needs of the local market.
Al Hajeri stated that the UAE has implemented best-in-class policies and strategies to maintain a strategic reserve, ensuring the availability of all essential medicines for citizens, residents, and visitors in adequate quantities and for extended periods.
He emphasized that strengthening pharmaceutical security is a firmly established national priority, underpinned by a comprehensive strategic vision that guarantees the sustainable availability, quality, and safety of medicines under all circumstances.
Al Hajeri further noted that the Emirates Drug Establishment follows a proactive approach based on risk assessment and emergency planning, reinforcing readiness and boosting public confidence in the country’s pharmaceutical system.
Dr. Fatima Al Kaabi, Director-General of the Emirates Drug Establishment, underscored that the sector maintains high levels of stability and preparedness, ensuring the continuous provision of medicines and medical supplies with sustained long-term availability, in line with the highest standards of quality and safety.
She explained that the Establishment carries out daily field monitoring and supervises medicine movement and stock levels at factories, warehouses, and storage facilities through integrated systems in collaboration with strategic partners.
This approach guarantees the uninterrupted availability of essential medicines and prevents shortages of key products, with pharmaceutical supply chains across the UAE operating normally.
Dr. Al Kaabi added that current indicators for medical product availability remain stable and reassuring, thanks to effective forward planning and strong partnerships with the Ministry of Health and Prevention, relevant authorities, and the private sector.
She concluded that pharmaceutical security is a cornerstone of healthcare in the UAE, with the Establishment adopting a forward-looking strategy to ensure sustainable
